Fedele receives 5-year R01 award

Dr. David FedeleDr. David Fedele received a 5-year R01 award (R01HL153119) from the National Heart, Lung, and Blood Institute to evaluate the efficacy of a mobile health tool aimed at improving asthma management among early adolescents (12-15 year-olds) with poorly controlled asthma.

Early adolescents diagnosed with asthma have difficulties consistently performing disease self-management behaviors, placing them at elevated risk for morbidity and impaired quality of life. The goal of this project is to address the critical need for improving health outcomes in early adolescents with poorly controlled asthma by conducting a randomized controlled trial of a novel intervention, delivered via smartphones, that aims to facilitate helpful caregiver support as early adolescents develop and master asthma self-management behaviors. If successful, the smartphone-based intervention has long-term potential in improving health outcomes for a large number of early adolescents diagnosed with asthma.